TIDMONG 
 
RNS Number : 9725U 
Oxford Nutrascience Group PLC 
26 October 2010 
 

 
Oxford Nutrascience Group plc 
("the Company") 
Patent granted for chewy confectionery compositions 
Oxford Nutrascience Group plc ("the Company") has been granted a 20 year UK 
patent (from the date of submission, 7 August 2006) for its chewy confectionery 
composition technology. The patent covers the Company's technology which allows 
sugars to be replaced with fibres and for the product to be fortified with 
vitamins and other nutraceutical ingredients. 
 
As outlined in the Company's admission document dated 8 February 2010 the 
application is listed under Patent Family 1, number 0615590.7. An application 
for a European chewy confectionery patent (number 07251302.1) was submitted on 
27 March 2007. The granting of the European patent is expected in due course. 
 
The Company recently announced the launch of its CHEWYZ(TM), a reduced sugar, 
high fibre, tasty, vitamin enriched soft chew. Every chew contains 50mg of Omega 
3, vitamins A, C, D & E and contain 35% fibre. Chewyz will initially be launched 
in Tesco Nutri Centre stores. 
 
 
Marcelo Bravo, Executive Chairman and Chief Technology Officer commented, 
 
"The granting of this patent in the UK strengthens the commercialisation of our 
chews. Our Chewyz product is healthier than any other chew currently available 
in the market. 
 
"This addition to our patent portfolio provides further validation of the 
Company's strategy of developing intellectual property that can be successfully 
exploited to build a business in the medicine and consumer healthcare sector." 
 
For further information: 
www.oxfordnutrascience.com 
 
Oxford Nutrascience Group Plc 
Nigel Theobald, Chief Executive +44 1865 854874 
Mark Way, Investor and Media Relations +44 7786 116991 
 
ZAI Corporate Finance (Nominated Adviser) 
John Depasquale +44 20 7060 2220 
Sarang Shah +44 20 7060 2220 
 
 
About Oxford Nutrascience Group Plc 
 
·      Oxford Nutrascience is a UK consumer healthcare company that develops 
chewy confectionery, chewable tablets and liquid suspensions to allow medicines 
and vitamin supplements to be taken in a more pleasant and convenient way. 
 
·      Oxford Nutrascience has developed technology for the use of soluble 
fibres in medicine delivery systems that disperse and solubilise medicines, 
improve taste and mouth feel, simplify processing and eliminate additives, 
incorporate prebiotic health benefits. 
 
·      Chews: Oxford Nutrascience currently produces Ellactiva , a calcium chewy 
supplement sold in the UK and in the Middle East, and plans to launch new chews 
to complement this existing product. 
 
·      Chewable tablets and liquid suspensions: The target market for Oxford 
Nutrasciences' Chewitabs(TM) and liquid suspension delivery systems are 
over-the-counter ("OTC") pain relieving drugs, indigestion preparations and 
cough and cold medicines. 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 MSCFESFIIFSSELS 
 

Grafico Azioni Oxford Nutrascience (LSE:ONG)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Oxford Nutrascience
Grafico Azioni Oxford Nutrascience (LSE:ONG)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Oxford Nutrascience